The Securities Issue Committee of the Board of Directors of the Company vide a resolution passed on December 24, 2024, has allotted 3,038 equity shares of Re.1 each of the Company under Scheme XX (Part 1) of ESOP 2016, to the eligible grantee, pursuant to exercise of stock options granted thereunder.